Does LAPATINIB DITOSYLATE Cause Off label use? 141 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 141 reports of Off label use have been filed in association with LAPATINIB DITOSYLATE (Lapatinib). This represents 3.6% of all adverse event reports for LAPATINIB DITOSYLATE.
141
Reports of Off label use with LAPATINIB DITOSYLATE
3.6%
of all LAPATINIB DITOSYLATE reports
3
Deaths
42
Hospitalizations
How Dangerous Is Off label use From LAPATINIB DITOSYLATE?
Of the 141 reports, 3 (2.1%) resulted in death, 42 (29.8%) required hospitalization, and 8 (5.7%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LAPATINIB DITOSYLATE. However, 141 reports have been filed with the FAERS database.
What Other Side Effects Does LAPATINIB DITOSYLATE Cause?
Diarrhoea (893)
Death (665)
Nausea (317)
Fatigue (301)
Vomiting (259)
Rash (249)
Drug ineffective (183)
Malignant neoplasm progression (183)
Disease progression (137)
Palmar-plantar erythrodysaesthesia syndrome (135)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which LAPATINIB DITOSYLATE Alternatives Have Lower Off label use Risk?
LAPATINIB DITOSYLATE vs LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN
LAPATINIB DITOSYLATE vs LARONIDASE
LAPATINIB DITOSYLATE vs LAROTRECTINIB
LAPATINIB DITOSYLATE vs LASILIX
LAPATINIB DITOSYLATE vs LASIX